Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro

BACKGROUND: Previous studies on animal models have suggested that δ-opioid receptor (OR) signaling is the primary pathway responsible for opioids' cardioprotective effect. We hypothesize that the μ-OR's activation protects the human heart muscle. METHODS: We performed the experiments on mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunecki, Marcin, Oleksy, Tomasz, Martynów, Jan, Zygmunt, Michalina, Deja, Marek, Kargul, Tomasz, Biernat, Jolanta, Podolec, Piotr, Gołba, Krzysztof S., Płazak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120098/
https://www.ncbi.nlm.nih.gov/pubmed/37081569
http://dx.doi.org/10.1186/s40360-023-00660-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120098/
https://www.ncbi.nlm.nih.gov/pubmed/37081569
http://dx.doi.org/10.1186/s40360-023-00660-3

Ejemplares similares